Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel and Carboplatin in Recurrent Ovarian Cancer
NCT00214058Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Aug 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin in ovarian carcinoma, primary peritoneal carcinoma (PPC), sponsored by University of Wisconsin–Madison. Started Aug 2002; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00214058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214058.